QuidelOrtho (QDEL) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 28, 2026
- EPS actual
- $0.13
- EPS estimate
- −$0.05
- EPS surprise
- +366.39%
- Revenue surprise
- +1.97%
- Revenue
- $630.9M
- Revenue estimate
- $618.7M
- Reported
- Aug 6, 2026
QuidelOrtho reported Q2 2026 results on August 6, 2026. EPS was $0.13 against an expected loss of $0.05, a 366.39% beat. Revenue of $630.9 million topped the $618.7 million estimate by 1.97%. Compared with Q2 2025, EPS rose from $0.12, and revenue rose about 3% from $613.9 million.
Earnings in the table have come down sharply from early highs. Q1 2022 brought EPS of $11.66 and revenue of $1.0 billion, both the highest here. Annual EPS fell from $17.61 in 2022 to $4.13 in 2023 and $1.85 in 2024, then rose to $2.12 in 2025. Revenue slipped each year, from about $3.26 billion in 2022 to $2.73 billion in 2025. From 2023 to 2025, Q2 was the weakest quarter of each year. Losses came in Q2 2024 and Q1 2026, at $0.07 and $0.04 per share. The first half of 2026 totals $0.09 per share, against $0.86 a year earlier. QuidelOrtho beat the EPS estimate in 16 of 20 quarters.
Q3 results have come between November 1 and November 7 in each of the past five years. That points to early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.05 | $0.13 | +366.39% | $630.9M | SEC |
| Q1 2026 | May 5, 2026 | $0.36 | −$0.04 | −111.20% | $619.8M | SEC |
| Q4 2025 | Feb 11, 2026 | $0.42 | $0.46 | +9.08% | $723.6M | SEC |
| Q3 2025 | Nov 5, 2025 | $0.51 | $0.80 | +55.37% | $699.9M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.00 | $0.12 | +7900.00% | $613.9M | SEC |
| Q1 2025 | May 7, 2025 | $0.59 | $0.74 | +26.15% | $692.8M | SEC |
| Q4 2024 | Feb 12, 2025 | $0.59 | $0.63 | +6.65% | $707.8M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.27 | $0.85 | +213.65% | $727.1M | SEC |
| Q2 2024 | Jul 31, 2024 | −$0.23 | −$0.07 | +69.97% | $637.0M | SEC |
| Q1 2024 | May 8, 2024 | $0.39 | $0.44 | +12.79% | $711.0M | SEC |
| Q4 2023 | Feb 13, 2024 | $2.04 | $1.17 | −42.60% | $742.6M | SEC |
| Q3 2023 | Nov 1, 2023 | $0.60 | $0.90 | +50.63% | $744.0M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.28 | $0.26 | −6.71% | $665.1M | SEC |
| Q1 2023 | May 3, 2023 | $1.49 | $1.80 | +20.58% | $846.1M | SEC |
| Q4 2022 | Feb 15, 2023 | $1.43 | $1.76 | +23.37% | $866.5M | SEC |
| Q3 2022 | Nov 2, 2022 | $0.74 | $1.85 | +149.70% | $783.8M | SEC |
| Q2 2022 | Aug 4, 2022 | $2.68 | $2.34 | −12.80% | $613.4M | SEC |
| Q1 2022 | May 4, 2022 | $9.89 | $11.66 | +17.88% | $1.0B | SEC |
| Q4 2021 | Feb 17, 2022 | $5.61 | $7.29 | +30.00% | $636.9M | SEC |
| Q3 2021 | Nov 4, 2021 | $3.52 | $5.36 | +52.10% | $509.7M | SEC |
Quarterly revenue
Frequently asked questions
When did QuidelOrtho (QDEL) last report earnings?
QuidelOrtho last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did QDEL beat earnings estimates?
Yes. QuidelOrtho reported EPS of $0.13 for Q2 2026 against a −$0.05 estimate — a 366.39% beat.
How much revenue did QDEL report last quarter?
QuidelOrtho reported $630.9M in revenue for Q2 2026, against a consensus estimate of $618.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.